JP2016515563A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016515563A5 JP2016515563A5 JP2016504675A JP2016504675A JP2016515563A5 JP 2016515563 A5 JP2016515563 A5 JP 2016515563A5 JP 2016504675 A JP2016504675 A JP 2016504675A JP 2016504675 A JP2016504675 A JP 2016504675A JP 2016515563 A5 JP2016515563 A5 JP 2016515563A5
- Authority
- JP
- Japan
- Prior art keywords
- copolymer
- restenosis
- compound
- pharmaceutical formulation
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361805716P | 2013-03-27 | 2013-03-27 | |
| US61/805,716 | 2013-03-27 | ||
| PCT/EP2014/056157 WO2014154804A1 (en) | 2013-03-27 | 2014-03-27 | Pharmaceutical formulation for use in the treatment and/or prevention of restenosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016515563A JP2016515563A (ja) | 2016-05-30 |
| JP2016515563A5 true JP2016515563A5 (https=) | 2017-05-18 |
| JP6411454B2 JP6411454B2 (ja) | 2018-10-24 |
Family
ID=50478367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016504675A Active JP6411454B2 (ja) | 2013-03-27 | 2014-03-27 | 再狭窄の治療および／または予防に用いられる医薬製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10363227B2 (https=) |
| EP (1) | EP2978408B1 (https=) |
| JP (1) | JP6411454B2 (https=) |
| CN (1) | CN105188667A (https=) |
| BR (1) | BR112015024703A2 (https=) |
| CA (1) | CA2903993C (https=) |
| MX (1) | MX2015013755A (https=) |
| WO (1) | WO2014154804A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10202107829YA (en) | 2017-03-22 | 2021-08-30 | Genentech Inc | Hydrogel cross-linked hyaluronic acid prodrug compositions and methods |
| CN107335100A (zh) * | 2017-07-31 | 2017-11-10 | 首都医科大学附属北京安贞医院 | 一种冠状动脉旁路移植术预防桥血管再狭窄系统 |
| CN108210927B (zh) * | 2018-03-07 | 2020-03-13 | 郎济禄 | 一种用于治疗动脉粥样硬化的药物组合物 |
| US20220133616A1 (en) * | 2020-11-05 | 2022-05-05 | Robin James Evans | Compositions, Methods and Uses for Treating Skin Aging |
| CN114522253B (zh) * | 2021-12-24 | 2023-05-26 | 重庆医科大学附属第二医院 | 多功能纳米粒及其制备方法、应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1259100B (it) * | 1992-05-20 | 1996-03-11 | Lanfranco Callegaro | Uso di idrogeli per il bloccaggio di sistemi protesici |
| ES2388248T3 (es) * | 1997-03-31 | 2012-10-11 | Boston Scientific Scimed Limited | Forma de dosificación que comprende taxol en forma cristalina |
| US6716445B2 (en) * | 1999-04-12 | 2004-04-06 | Cornell Research Foundation, Inc. | Hydrogel entrapping therapeutic agent and stent with coating comprising this |
| EP1168934B1 (en) * | 1999-04-12 | 2008-02-13 | Cornell Research Foundation, Inc. | Hydrogel-forming system with hydrophobic and hydrophilic components |
| JP2003520830A (ja) * | 2000-01-25 | 2003-07-08 | エドワーズ ライフサイエンシーズ コーポレイション | 再狭窄および吻合内膜過形成処置のための送達系 |
| US20040018228A1 (en) * | 2000-11-06 | 2004-01-29 | Afmedica, Inc. | Compositions and methods for reducing scar tissue formation |
| JP2004533293A (ja) * | 2001-04-27 | 2004-11-04 | ザ、メッドスター、リサーチ、インスチツート | 再狭窄の予防のためのステントベースのスタチン類の送達 |
| JP2008512350A (ja) * | 2004-07-01 | 2008-04-24 | イェール ユニバーシティ | 標的化され、そして高密度で薬物が負荷されるポリマー性物質 |
| ES2330993B1 (es) * | 2005-07-15 | 2010-07-06 | Laboratorios Del Dr. Esteve, S.A. | Combinacion de antagonista del receptor de cannabinoides de tipo pirazolina y estatina. |
| US8663674B2 (en) * | 2006-01-13 | 2014-03-04 | Surmodics, Inc. | Microparticle containing matrices for drug delivery |
| US9308190B2 (en) * | 2011-06-06 | 2016-04-12 | Warsaw Orthopedic, Inc. | Methods and compositions to enhance bone growth comprising a statin |
-
2014
- 2014-03-27 WO PCT/EP2014/056157 patent/WO2014154804A1/en not_active Ceased
- 2014-03-27 JP JP2016504675A patent/JP6411454B2/ja active Active
- 2014-03-27 BR BR112015024703A patent/BR112015024703A2/pt not_active Application Discontinuation
- 2014-03-27 US US14/779,985 patent/US10363227B2/en active Active
- 2014-03-27 MX MX2015013755A patent/MX2015013755A/es unknown
- 2014-03-27 CA CA2903993A patent/CA2903993C/en active Active
- 2014-03-27 EP EP14716527.8A patent/EP2978408B1/en active Active
- 2014-03-27 CN CN201480019062.5A patent/CN105188667A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016515563A5 (https=) | ||
| Fatehi Hassanabad et al. | Prevention of post-operative adhesions: a comprehensive review of present and emerging strategies | |
| IL265774A (en) | Diagnosis, prevention and treatment of joint diseases | |
| AU2006315238B2 (en) | Injectable formulation capable of forming a drug-releasing device | |
| AR081032A1 (es) | Formulacion farmaceutica en forma de comprimidos de dos capas que comprenden inhibidor de hmg-coa reductasa e irbesartan | |
| NZ607797A (en) | Corticosteroids for the treatment of joint pain | |
| JP2007277267A5 (https=) | ||
| WO2008127889A3 (en) | Degradable polymers incorporating gamma- butyrolactone | |
| US9782432B2 (en) | Polymers and methods thereof for wound healing | |
| JP2011508791A5 (https=) | ||
| JP2013514971A5 (https=) | ||
| WO2016114216A1 (ja) | 生分解性ステント | |
| ES2422681T3 (es) | Formulación de fármaco de moléculas pequeñas de liberación prolongada | |
| BR112014029349A2 (pt) | métodos, sistemas e dispositivos para administração de fármacos e oclusão vascular | |
| JP2014504170A5 (https=) | ||
| Bertesteanu et al. | Biomedical applications of synthetic, biodegradable polymers for the development of anti-infective strategies | |
| JP2006512361A5 (https=) | ||
| HK1208383A1 (en) | Bioresorbable polymer peripheral scaffolds made from block copolymers of poly(l-lactide) and hydrophilic polymers | |
| RU2004127193A (ru) | Лекарственные препараты с активными веществами, понижающими уровень холестерина, с отсроченным высвобождением активного вещества | |
| AR080023A1 (es) | Formulacion de complejos que comprende aspirina revestida con una barrera que contiene aditivo hidrofobo e inhibidor de la hmg-coa reductasa | |
| US10363227B2 (en) | Pharmaceutical formulation for use in the treatment and/or prevention of restenosis | |
| AR096350A1 (es) | Composición farmacéutica para administración por vía oral para su uso para la prevención y/o el tratamiento de una enfermedad cardiovascular | |
| US8936635B2 (en) | Bioresorbable nitric oxide agonist prodrug scaffolds for vascular stents | |
| Peppas et al. | Highly cited research articles in Journal of Controlled Release: Commentaries and perspectives by authors | |
| RU2014104678A (ru) | Имплантируемый стент |